Use of imatinib mesylate in CML patients autografted in the pre-imatinib mesylate era: A single center experience.

被引:0
|
作者
Liesveld, JL [1 ]
Nichols, D [1 ]
Ifthikharuddin, JJ [1 ]
Lancet, JE [1 ]
Abboud, CN [1 ]
机构
[1] Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5471
引用
下载
收藏
页码:473B / 473B
页数:1
相关论文
共 50 条
  • [1] Excellent outcomes of children with CML treated with imatinib mesylate compared to that in pre-imatinib era
    Muramatsu, Hideki
    Takahashi, Yoshiyuki
    Sakaguchi, Hirotoshi
    Shimada, Akira
    Nishio, Nobuhiro
    Hama, Asahito
    Doisaki, Sayoko
    Yagasaki, Hiroshi
    Matsumoto, Kimikazu
    Kato, Koji
    Kojima, Seiji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (02) : 186 - 191
  • [2] Excellent outcomes of children with CML treated with imatinib mesylate compared to that in pre-imatinib era
    Hideki Muramatsu
    Yoshiyuki Takahashi
    Hirotoshi Sakaguchi
    Akira Shimada
    Nobuhiro Nishio
    Asahito Hama
    Sayoko Doisaki
    Hiroshi Yagasaki
    Kimikazu Matsumoto
    Koji Kato
    Seiji Kojima
    International Journal of Hematology, 2011, 93 : 186 - 191
  • [3] HyperCKemia in CML patients on imatinib mesylate
    Hewitt, Joanne D.
    Rusnak, Deborah A.
    Cox-Kenneth, Nanette
    Larratt, Loree M.
    Turner, Robert
    BLOOD, 2007, 110 (11) : 871A - 871A
  • [4] Management of gastrointestinal stromal tumors: a single center experience in the pre-Imatinib era
    Jindal, S.
    Singhal, D.
    Kakodkar, R.
    Gupta, S.
    Soin, A.
    Chaudhary, A.
    Nundy, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A162 - A163
  • [5] Imatinib mesylate in chronic myeloid leukemia (CML): A single institution experience of 174 patients
    Deshmukh, CD
    Saikia, T
    Bakshi, AV
    Parikh, PM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 610S - 610S
  • [6] OUTCOME OF GIST'S WITH IMATINIB MESYLATE: AN INDIAN EXPERIENCE.
    Purohit, Samit
    Lakshmaiah, K.
    Bhise, Rohan
    Jacob, Linu
    Suresh, M.
    Lokanatha, D.
    Govindbabu, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 67 - 67
  • [7] Imatinib mesylate induces massive and nonspecific aminoaciduria in CML patients
    Ianotto, Jean-Christophe
    Tempescul, Adrian
    Amet, Yolande
    Grall, Pauline
    Dalbies, Florence
    Eveillard, Jean-Richard
    Guillerm, Gaelle
    Berthou, Christian
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (04) : 437 - 439
  • [8] Multicenter experience with imatinib, mesylate in newly diagnosed chronic myeloid leukemia (CML) patients
    Carella, A. M.
    Lerma, E.
    Orlandi, E.
    Lazzarino, M.
    Annunziata, M.
    Ferrara, F.
    Pungolino, E.
    Morra, E.
    Miglino, M.
    Gobbi, M.
    BLOOD, 2007, 110 (11) : 210B - 210B
  • [9] Results of imatinib mesylate therapy in chronic myeloid leukemia: Experience of a single center
    Pasa, S.
    Boyraz, T.
    Beyaz, C.
    Sayar, S.
    Atayan, Y.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 530 - 530
  • [10] IMATINIB MESYLATE INDUCED HEPATOTOXICITY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML)
    Milosevic, V.
    Bogdanovic, A.
    Djordjevic, V.
    Fekete, M. Dencic
    Mihaljevic, B.
    Gotic, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 545 - 546